Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J B Engel

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Anticancer Research|July 2, 2010
Expression of transketolase-like 1 protein (TKTL1) in human endometrial cancerM Krockenberger, J B Engel, M Schmidt, et al.
Anticancer Research|May 18, 2012
Peptidomimetic GnRH antagonist AEZS-115 inhibits the growth of ovarian and endometrial cancer cellsJ B Engel, J C Hahne, S F M Häusler, et al.
Oncology Reports|April 30, 2013
Combination of GHRH antagonists and docetaxel shows experimental effectiveness for the treatment of triple-negative breast cancersS Seitz, F G Rick, A V Schally, et al.
Oncology Reports|September 21, 2012
Downregulation of AKT reverses platinum resistance of human ovarian cancers in vitroJ C Hahne, A Honig, S R Meyer, et al.
British Journal of Cancer|August 5, 2010
Whole blood-derived miRNA profiles as potential new tools for ovarian cancer screeningS F M Häusler, A Keller, P A Chandran, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 2009
Expression of neuropeptide hormone receptors in human adrenal tumors and cell lines: antiproliferative effects of peptide analoguesC G Ziegler, J W Brown, A V Schally, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Anticancer Research|July 2, 2010
Expression of transketolase-like 1 protein (TKTL1) in human endometrial cancerM Krockenberger, J B Engel, M Schmidt, et al.
Anticancer Research|May 18, 2012
Peptidomimetic GnRH antagonist AEZS-115 inhibits the growth of ovarian and endometrial cancer cellsJ B Engel, J C Hahne, S F M Häusler, et al.
Oncology Reports|April 30, 2013
Combination of GHRH antagonists and docetaxel shows experimental effectiveness for the treatment of triple-negative breast cancersS Seitz, F G Rick, A V Schally, et al.
Oncology Reports|September 21, 2012
Downregulation of AKT reverses platinum resistance of human ovarian cancers in vitroJ C Hahne, A Honig, S R Meyer, et al.
British Journal of Cancer|August 5, 2010
Whole blood-derived miRNA profiles as potential new tools for ovarian cancer screeningS F M Häusler, A Keller, P A Chandran, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 2009
Expression of neuropeptide hormone receptors in human adrenal tumors and cell lines: antiproliferative effects of peptide analoguesC G Ziegler, J W Brown, A V Schally, et al.
Pageof 3